Impacts of β agonists and pro-inflammatory cytokines on ... · Impacts of β agonists and...

1
Impacts of β agonists and pro-inflammatory cytokines on basal and insulin-stimulated glucose metabolism in rat soleus. C. N. Cadaret, K. A. Beede , H. E. Riley and D. T. Yates Department of Animal Science, University of Nebraska - Lincoln Abstract Recent studies suggest that catecholamines and pro-inflammatory cytokines help regulate muscle growth and metabolism at sub-stress levels. Our objective was to determine acute effects of β1 and β2 adrenergic agonists, TNFα, and IL-6 on muscle glucose uptake and oxidation under basal and insulin-stimulated conditions. Soleus muscles from adult Sprague-Dawley rats were separated into 25-45mg strips and incubated in KHB spiked with insulin, ractopamine (β1 agonist), zilpaterol (β2 agonist), TNFα, or IL-6. Glucose uptake was determined from cellular accumulation of [3H]-2- deoxyglucose after 20min. Glucose oxidation of [14C-U]-glucose was determined after 2h. Phospho-Akt/total Akt (p- Akt/Akt) was determined after 1h. Compared to muscle incubated in un-spiked (basal) media, incubation with insulin increased (P<0.05) glucose uptake by ~47%, oxidation by ~32%, and p-Akt/Akt by ~238%. Muscle incubated with β2 agonist exhibited ~20% less (P<0.05) glucose uptake but ~32% greater (P<0.05) oxidation than basal. Moreover, β2 agonist+insulin increased (P<0.05) glucose oxidation and p-Akt/Akt over insulin alone. β1 agonist incubations did not differ from basal for any output. Likewise, β1 agonist+insulin incubations did not differ from insulin alone. Glucose oxidation was ~23% and ~33% greater (P<0.05), respectively, in TNFα and IL-6 incubations compared to basal, yet uptake and p-Akt/Akt did not differ. Glucose uptake, oxidation, and p-Akt/Akt were similar among TNFα+insulin, IL- 6+insulin, and insulin alone. In addition, glucose oxidation in TNFα+insulin and IL-6+insulin incubations did not differ from TNFα or IL-6 alone. These results show that acute β2 stimulation had opposite effects on muscle glucose uptake and oxidation, and that acute β1 stimulation had no evident metabolic impact. Moreover, β2 stimulation was synergistic with insulin, as glucose oxidation and Akt phosphorylation were greater with both agents together than either individually. Lastly, acute cytokine stimulation increased glucose oxidation independently of insulin or Akt phosphorylation. Together, our findings demonstrate that adrenergic and inflammatory mediators can have insulin-associated or insulin-independent effects on glucose metabolism and that these effects may differ for glucose uptake and oxidation. Introduction Skeletal muscle makes up <1/2 of total body mass but accounts for the majority of insulin-stimulated glucose utilization. Muscle glucose metabolism can be regulated by traditional “stress” factors of the adrenergic and inflammatory systems. However, it is unclear whether these factors act directly on metabolic pathways or indirectly through mediation of insulin action. In this study, we performed in vitro incubations of soleus muscle strips in order to better understand the impact of stress components on muscle glucose metabolism. We hypothesized that inflammatory and adrenergic factors illicit different effects on glucose uptake vs. oxidation and these effects may be insulin-associated or insulin-independent. 20-50mg strips of rat soleus muscle (4 strips/rat, 8 rats/condition) Culture Conditions Basal: No additive Insulin: 5mU/ml Humulin R β1 agonist: 10uM Ractopamine HCl β2 agonist: 0.5uM Zilpaterol HCl IL6: 1ng/ml rhIL-6 TNFα: 20ng/ml porcine TNFα Incubation Periods 1.) Pre-incubation: 1hr, KHB, 5mM glucose 2.) Wash: 20min, KHB, 0mM glucose 3.) Tracer KHB (below): Glucose Uptake a.) 20min incubation, KHB, 1mM [ 3 H] 2-deoxyglucose & 39mM [1- 14 C] mannitol b.) Strips were lysed with 0.5ml NaOH, mixed with 15ml UltimaGold scintillation fluid c.) Glucose uptake rate determined from [ 3 H] 2-deoxyglucose Specific Activity in lysate (less ECF) Extracellular fluid volume determined from [1- 14 C] mannitol Specific Activity in lysate Glucose Oxidation a.) 2hr incubation, KHB, 5mM [ 14 C-U] glucose b.) 14 CO 2 produced by muscle strips released by 2N HCl and captured in 1M NaOH NaOH mixed with 15ml UltimaGold scintillation fluid c.) Glucose oxidation rate determined from 14 CO 2 Specific Activity in NaOH Akt Phosphorylation a.) Muscle strips incubated in spiked KHB media (no tracer) for 1 hour b.) phosphorylated Akt (pAkt) and total Akt determined by western immunoblot Materials & Methods Middle Gasket: Separates each set of wells Top Gasket: Seals the system Bottom Gasket: Connects Incubation well with NaOH-containing Capture well Incubation Well: Muscle strip in treatment media Capture Well: 1ml 2N NaOH to capture 14 CO 2 40 55 70 85 100 115 Basal Insulin β1 β2 β1+Ins. β2+Ins. Glucose oxidation (nmol/mg/h) a c bc bc d ab 40 55 70 85 100 115 Basal Insulin β1 β2 β1+Ins. β2+Ins. Glucose uptake (nmol/mg/h) a c b b b a Results 40 55 70 85 100 115 Basal Insulin TNFα IL6 TNFα+Ins. IL6+Ins. Glucose uptake (nmol/mg/h) a a b b b a 40 55 70 85 100 115 Basal Insulin TNFα IL6 TNFα+Ins. IL6+Ins. Glucose oxidation (nmol/mg/h) a b b b b b a b a a b c 0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 Basal Insulin β1 β2 β1+Ins β2+Ins pAkt/total Akt (fold change from control) a b a a d a,d 0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 Basal Insulin TNF IL6 TNF+Ins IL6+Ins pAkt / total Akt (fold change from control) Figure 2: Glucose metabolism in primary muscle strips incubated with adrenergic and pro-inflammatory factors. Rates of glucose uptake (A, n=10) and glucose oxidation (B,n=9) determined from [ 3 H] 2-deoxyglucose and [ 14 C-U] glucose, respectively, are presented as mean + SEM. Means with differing superscripts are different (P < 0.05). Akt phosphorylation (C,n=8) during 1-h incubation in adrenergic and pro-inflammatory are presented as fold change from basal + SEM. Means with differing superscripts are different (P < 0.05). A B C Figure 1: A. Individual rubber gaskets that are combined to seal the six-well plate during oxidation studies. β2 agonist alone had opposite effects on glucose uptake (decreased) vs. glucose oxidation (increased) β2 agonist & insulin synergistically enhanced glucose oxidation more than either factor alone Cytokines impaired insulin-stimulated Akt phosphorylation but increased glucose oxidation directly, effectively “replacing” insulin (acutely) Implications Acknowledgements Supported by University of Nebraska-Lincoln Research Council Interdisciplinary Grant #737 & NE Center for Prevention of Obesity Diseases Pilot Project Grant (Parent NIH P20GM104320). Metabolic changes due to acute stress may initially be beneficial to energy production by muscle and may include compensation for reduced insulin action. Adrenergic stimulation appears to boost insulin’s metabolic actions. Together, our findings show that components of the stress response may help to maintain glucose metabolism during the initial onset of stress. With or w/o Insulin

Transcript of Impacts of β agonists and pro-inflammatory cytokines on ... · Impacts of β agonists and...

Page 1: Impacts of β agonists and pro-inflammatory cytokines on ... · Impacts of β agonists and pro-inflammatory cytokines on basal and insulin-stimulated glucose metabolism in rat soleus.

Impacts of β agonists and pro-inflammatory cytokines on basal and insulin-stimulated glucose metabolism in rat soleus.

C. N. Cadaret, K. A. Beede, H. E. Riley and D. T. Yates

Department of Animal Science, University of Nebraska-Lincoln

AbstractRecent studies suggest that catecholamines and pro-inflammatory cytokines help regulate muscle growth and

metabolism at sub-stress levels. Our objective was to determine acute effects of β1 and β2 adrenergic agonists, TNFα,

and IL-6 on muscle glucose uptake and oxidation under basal and insulin-stimulated conditions. Soleus muscles from

adult Sprague-Dawley rats were separated into 25-45mg strips and incubated in KHB spiked with insulin, ractopamine

(β1 agonist), zilpaterol (β2 agonist), TNFα, or IL-6. Glucose uptake was determined from cellular accumulation of [3H]-2-

deoxyglucose after 20min. Glucose oxidation of [14C-U]-glucose was determined after 2h. Phospho-Akt/total Akt (p-

Akt/Akt) was determined after 1h. Compared to muscle incubated in un-spiked (basal) media, incubation with insulin

increased (P<0.05) glucose uptake by ~47%, oxidation by ~32%, and p-Akt/Akt by ~238%. Muscle incubated with β2

agonist exhibited ~20% less (P<0.05) glucose uptake but ~32% greater (P<0.05) oxidation than basal. Moreover, β2

agonist+insulin increased (P<0.05) glucose oxidation and p-Akt/Akt over insulin alone. β1 agonist incubations did not

differ from basal for any output. Likewise, β1 agonist+insulin incubations did not differ from insulin alone. Glucose

oxidation was ~23% and ~33% greater (P<0.05), respectively, in TNFα and IL-6 incubations compared to basal, yet

uptake and p-Akt/Akt did not differ. Glucose uptake, oxidation, and p-Akt/Akt were similar among TNFα+insulin, IL-

6+insulin, and insulin alone. In addition, glucose oxidation in TNFα+insulin and IL-6+insulin incubations did not differ from

TNFα or IL-6 alone. These results show that acute β2 stimulation had opposite effects on muscle glucose uptake and

oxidation, and that acute β1 stimulation had no evident metabolic impact. Moreover, β2 stimulation was synergistic with

insulin, as glucose oxidation and Akt phosphorylation were greater with both agents together than either individually.

Lastly, acute cytokine stimulation increased glucose oxidation independently of insulin or Akt phosphorylation. Together,

our findings demonstrate that adrenergic and inflammatory mediators can have insulin-associated or insulin-independent

effects on glucose metabolism and that these effects may differ for glucose uptake and oxidation.

IntroductionSkeletal muscle makes up <1/2 of total body mass but accounts for the majority of insulin-stimulated glucose utilization.

Muscle glucose metabolism can be regulated by traditional “stress” factors of the adrenergic and inflammatory systems.

However, it is unclear whether these factors act directly on metabolic pathways or indirectly through mediation of insulin

action. In this study, we performed in vitro incubations of soleus muscle strips in order to better understand the impact

of stress components on muscle glucose metabolism. We hypothesized that inflammatory and adrenergic factors illicit

different effects on glucose uptake vs. oxidation and these effects may be insulin-associated or insulin-independent.

• 20-50mg strips of rat soleus muscle (4 strips/rat, 8 rats/condition)

• Culture Conditions

■ Basal: No additive

■ Insulin: 5mU/ml Humulin R

■ β1 agonist: 10uM Ractopamine HCl

■ β2 agonist: 0.5uM Zilpaterol HCl

■ IL6: 1ng/ml rhIL-6■ TNFα: 20ng/ml porcine TNFα

• Incubation Periods

1.) Pre-incubation: 1hr, KHB, 5mM glucose

2.) Wash: 20min, KHB, 0mM glucose

3.) Tracer KHB (below):

• Glucose Uptake

a.) 20min incubation, KHB, 1mM [3H] 2-deoxyglucose & 39mM [1-14C] mannitol

b.) Strips were lysed with 0.5ml NaOH, mixed with 15ml UltimaGold scintillation fluid

c.) Glucose uptake rate determined from [3H] 2-deoxyglucose Specific Activity in lysate (less ECF)

Extracellular fluid volume determined from [1-14C] mannitol Specific Activity in lysate

• Glucose Oxidation

a.) 2hr incubation, KHB, 5mM [14C-U] glucose

b.) 14CO2 produced by muscle strips released by 2N HCl and captured in 1M NaOH

NaOH mixed with 15ml UltimaGold scintillation fluid

c.) Glucose oxidation rate determined from 14CO2 Specific Activity in NaOH

• Akt Phosphorylation

a.) Muscle strips incubated in spiked KHB media (no tracer) for 1 hour

b.) phosphorylated Akt (pAkt) and total Akt determined by western immunoblot

Materials & Methods

Middle Gasket: Separates each set of

wells

Top Gasket: Seals the system

Bottom Gasket: Connects Incubation well

with NaOH-containing

Capture well

Incubation Well: Muscle strip in

treatment media

Capture Well: 1ml 2N NaOH to

capture 14CO2

40

55

70

85

100

115

Basal Insulin β1 β2 β1+Ins. β2+Ins.

Glu

co

se

ox

ida

tio

n

(nm

ol/m

g/h

)

a

c

bcbc

d

ab

40

55

70

85

100

115

Basal Insulin β1 β2 β1+Ins. β2+Ins.

Glu

co

se

up

take

(n

mo

l/m

g/h

)

a

c

b

b

b

a

Results

40

55

70

85

100

115

Basal Insulin TNFα IL6 TNFα+Ins. IL6+Ins.

Glu

co

se

up

take

(n

mo

l/m

g/h

)

a

a

b

b

b

a

40

55

70

85

100

115

Basal Insulin TNFα IL6 TNFα+Ins. IL6+Ins.

Glu

co

se

ox

ida

tio

n

(nm

ol/m

g/h

)

a

bbb

b

b

a

b

a a

b

c

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

Basal Insulin β1 β2 β1+Ins β2+Ins

pA

kt/

tota

l A

kt

(fo

ld c

han

ge f

rom

co

ntr

ol)

a

b

a a

d

a,d

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

Basal Insulin TNF IL6 TNF+Ins IL6+Ins

pA

kt

/ to

tal A

kt

(fo

ld c

han

ge f

rom

co

ntr

ol)

Figure 2: Glucose metabolism in primary muscle strips incubated with adrenergic and pro-inflammatory factors. Rates of glucose uptake (A,

n=10) and glucose oxidation (B,n=9) determined from [3H] 2-deoxyglucose and [14C-U] glucose, respectively, are presented as mean + SEM.

Means with differing superscripts are different (P < 0.05). Akt phosphorylation (C,n=8) during 1-h incubation in adrenergic and pro-inflammatory are presented as fold change from basal + SEM. Means with differing superscripts are different (P < 0.05).

A

B

C

Figure 1: A. Individual rubber gaskets that are combined to seal the six-well plate during oxidation studies.

β2 agonist alone had opposite effects on glucose uptake (decreased) vs. glucose oxidation (increased)

β2 agonist & insulin synergistically enhanced glucose oxidation more than either factor alone

Cytokines impaired insulin-stimulated Akt

phosphorylation but increased glucose oxidation

directly, effectively “replacing” insulin (acutely)

Implications

Acknowledgements

Supported by University of Nebraska-Lincoln Research Council Interdisciplinary Grant #737 & NE Center

for Prevention of Obesity Diseases Pilot Project Grant (Parent NIH P20GM104320).

Metabolic changes due to acute stress may initially be beneficial to energy

production by muscle and may include compensation for reduced insulin action.

Adrenergic stimulation appears to boost insulin’s metabolic actions. Together, our

findings show that components of the stress response may help to maintain glucose

metabolism during the initial onset of stress.

With or

w/o Insulin